<div class="container">

<table style="width: 100%;"><tr>
<td>TRR.RTR.RRT</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>
Reference Datasets for TRR|RTR|RRT (partial) Replicate Designs
</h2>

<h3>Description</h3>

<p>Datasets from the public domain or simulated to be evaluated by <code>method.A()</code>, <code>method.B()</code>, or <code>ABE()</code>.
</p>


<h3>Format</h3>


<ul>
<li>
<p> Reference Dataset 02<br>
24 subjects.<br>
Balanced (eight subjects in each of the three sequences) and complete (no missing data). No outliers.<br>
A data frame with 72 observations on the following 6 variables:
</p>

<dl>
<dt>rds02</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
              <code>subject</code> </td>
<td style="text-align: left;"> a factor with 24 levels: 1, 2, ..., 24</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>period</code> </td>
<td style="text-align: left;"> a factor with 3 levels: 1, 2, 3</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 3 levels: TRR, RTR, RRT</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses acceptable for reference-scaling (generally C<sub>max</sub>)</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>logPK</code> </td>
<td style="text-align: left;"> a numeric vector of the natural logarithms of <code>PK</code>
            </td>
</tr>
</table>
</dd>
</dl>
<p>In the source evaluated by <abbr><span class="acronym">SAS</span></abbr> v9.1 for <abbr><span class="acronym">ABEL</span></abbr>. Reported results:
</p>
<dl>
<dt>SAS Proc GLM</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
              <code>CVwR</code> </td>
<td style="text-align: left;"> 11.2%</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>PE</code> </td>
<td style="text-align: left;"> 102.26% (Method A and B)</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>90% CI</code> </td>
<td style="text-align: left;"> 97.32% – 107.46% (Method A and B)
            </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference Dataset 04<br>
Data set of Table II given by Patterson &amp; Jones. 51 subjects.<br>
Balanced (17 subjects in each of the three sequences) and complete. No outliers.<br>
A data frame with 153 observations on the following 5 variables:
</p>

<dl>
<dt>rds04</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
              <code>subject</code> </td>
<td style="text-align: left;"> a factor with 51 levels: 1, 2, ..., 56</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>period</code> </td>
<td style="text-align: left;"> a factor with 3 levels: 1, 2, 3</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 3 levels: TRR, RTR, RRT</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses (here C<sub>max</sub>)
            </td>
</tr>
</table>
</dd>
</dl>
<p>In the source evaluated by <abbr><span class="acronym">SAS</span></abbr> with the <abbr><span class="acronym">FDA</span></abbr>’s mixed effects model (termed ‘Method C’ by the <abbr><span class="acronym">EMA</span></abbr>; not compatible with the guideline). Reported results:
</p>
<dl>
<dt>SAS Proc MIXED</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
              <code>CVwR</code> </td>
<td style="text-align: left;"> 61%</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>PE</code> </td>
<td style="text-align: left;"> 137%</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>90% CI</code> </td>
<td style="text-align: left;"> 119% – 159%
            </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference Dataset 07<br>
Simulated with CV<sub>wT</sub> = CV<sub>wR</sub> = 35%, GMR 0.90. 360 subjects.<br>
Balanced (120 subjects in each of the three sequences) and complete. No outliers.<br>
A data frame with 1,080 observations on the following 5 variables:
</p>

<dl>
<dt>rds07</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
              <code>subject</code> </td>
<td style="text-align: left;"> a factor with 360 levels: 1, 2, ..., 360</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>period</code> </td>
<td style="text-align: left;"> a factor with 3 levels: 1, 2, 3</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 3 levels: TRR, RTR, RRT</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses (generally C<sub>max</sub>)
            </td>
</tr>
</table>
</dd>
</dl>
</li>
<li>
<p> Reference Dataset 30<br>
Simulated with heteroscedasticity (CV<sub>wT</sub> = 14%, CV<sub>wR</sub> = 28%, CV<sub>bT</sub> = 28%, CV<sub>bR</sub> = 56%), GMR = 0.90. 12 subjects. 14 subjects.<br>
Imbalanced (six subjects in sequence TRR, five in RTR, and three RRT) and incomplete (two missings in sequences TRR and RTR and three in sequence RRT). Missings / period: 0/1, 0/2, 7/3. No outliers.<br>
A data frame with 35 observations on the following 5 variables:
</p>

<dl>
<dt>rds30</dt>
<dd>

<table>
<tr>
<td style="text-align: left;">
              <code>subject</code> </td>
<td style="text-align: left;"> a factor with 14 levels: 1, 2, ..., 39</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>period</code> </td>
<td style="text-align: left;"> a factor with 3 levels: 1, 2, 3</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>sequence</code> </td>
<td style="text-align: left;"> a factor with 3 levels: TRR, RTR, RRT</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>treatment</code> </td>
<td style="text-align: left;"> a factor with 2 levels: T, R</td>
</tr>
<tr>
<td style="text-align: left;">
              <code>PK</code> </td>
<td style="text-align: left;"> a numeric vector of pharmacokinetic responses (generally C<sub>max</sub>)
            </td>
</tr>
</table>
</dd>
</dl>
</li>
</ul>
<h3>Details</h3>


<table>
<tr>
<td style="text-align: center;">
      Dataset </td>
<td style="text-align: right;"> N </td>
<td style="text-align: center;"> CV<sub>wR</sub> (%) </td>
<td style="text-align: left;"> Evaluation</td>
</tr>
<tr>
<td style="text-align: center;">
      <code>rds02</code> </td>
<td style="text-align: right;"> 24 </td>
<td style="text-align: center;"> &lt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>, <code>ABE()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
      <code>rds04</code> </td>
<td style="text-align: right;"> 51 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
      <code>rds07</code> </td>
<td style="text-align: right;"> 360 </td>
<td style="text-align: center;"> &gt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>
</td>
</tr>
<tr>
<td style="text-align: center;">
      <code>rds30</code> </td>
<td style="text-align: right;"> 14 </td>
<td style="text-align: center;"> &lt;30 </td>
<td style="text-align: left;"> <code>method.A()</code>, <code>method.B()</code>, <code>ABE()</code>
  </td>
</tr>
</table>
<h3>Note</h3>

<p>In software sequences and treatments are ranked in lexical order. Hence, executing <code>str()</code> or <code>summary()</code> will show <code>sequence</code> as <code>"RRT", "RTR", "TRR"</code> and <code>treatment</code> as <code>"R", "T"</code>. In <abbr><span class="acronym">BE</span></abbr> – by convention – sequences are ordered with <code>T</code> first. The package follows this convention.
</p>


<h3>Author(s)</h3>

<p>Helmut Schütz (R-code for simulations by Detlew Labes)
</p>


<h3>Source</h3>


<table>
<tr>
<td style="text-align: center;">
    Dataset </td>
<td style="text-align: left;"> Origin </td>
<td style="text-align: left;"> Description</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds02</code> </td>
<td style="text-align: left;"> EMA </td>
<td style="text-align: left;"> Annex III.</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds04</code> </td>
<td style="text-align: left;"> Patterson &amp; Jones </td>
<td style="text-align: left;"> C<sub>max</sub> data of Table II.</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds07</code> </td>
<td style="text-align: left;"> R </td>
<td style="text-align: left;"> Large simulated data set with homoscedasticity.</td>
</tr>
<tr>
<td style="text-align: center;">
    <code>rds30</code> </td>
<td style="text-align: left;"> R </td>
<td style="text-align: left;"> Simulated with heteroscedasticity; imbalanced and incomplete.
  </td>
</tr>
</table>
<h3>References</h3>

<p>European Medicines Agency. London, 21 September 2016. <a href="https://www.ema.europa.eu/en/documents/other/31-annex-i-statistical-analysis-methods-compatible-ema-bioequivalence-guideline_en.pdf"><em>Annex I</em></a>, <a href="https://www.ema.europa.eu/en/documents/other/statistical-method-equivalence-studies-annex-iii_en.pdf"><em>Annex III</em></a>.
</p>
<p>Patterson SD, Jones B. <em>Viewpoint: observations on scaled average bioequivalence.</em> Pharm Stat. 2012; 11(1): 1–7. <a href="https://doi.org/10.1002/pst.498">doi:10.1002/pst.498</a>
</p>


<h3>Examples</h3>

<pre><code class="language-R">str(rds02)
row &lt;- c(10:12, 1:3, 16:18)
rds02[row, ]
summary(rds02[2:6])
</code></pre>


</div>